Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes

被引:49
作者
Arigita, C
Kersten, GFA
Hazendonk, T
Hennink, WE
Crommelin, DJA
Jiskoot, W
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Fac Pharm, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] Natl Inst Publ Hlth & Environm, Lab Prod & Proc Dev, NL-3720 BA Bilthoven, Netherlands
关键词
Neisseria meningitidis; PorA; presentation form; protein conformation; immunogenicity;
D O I
10.1016/S0264-410X(02)00546-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of the conformation, lipooligosaccharide (LOS)-depletion and the presentation form of outer membrane protein PorA from Neisseria meningitidis (PorA) subtype P1.7-2,4 on the immune response in mice was studied. Native PorA was purified from outer membrane vesicles (OMVs) derived from meningococci and reconstituted into liposomes. The conformation of PorA after purification from OMVs and reconstitution in liposomes was monitored by use of electrophoretic and spectroscopic techniques and compared with the conformation of PorA in outer membrane complexes (OMCs) and heat-denatured PorA. The antigenicity of the PorA formulations was measured by ELISA by using a bactericidal anti-P1.4 monoclonal antibody. Immunogenicity was determined in Balb/c mice. PorA-specific IgG, isotype distribution and bactericidal activity were measured after subcutaneous immunization. In all formulations except in heat-denatured OMVs, PorA was present as trimers. The lipooligosaccharide (LOS) content was reduced by 96% in the purified protein with respect to the original OMVs. The antigenicity of purified PorA (i.e. ELISA response) was substantially higher as compared to PorA in liposomes, OMVs or OMCs. The results of the immunogenicity studies showed that all formulations were able to induce comparable IgG titers. However, whereas the antibodies raised by OMVs were bactericidal, the antibodies elicited by immunization with purified PorA were unable to kill meningococci. Remarkably, the ability to induce bactericidal antibodies was fully recovered by incorporation of the purified PorA into liposomes, in the absence of other adjuvants, as compared to LOS-containing OMVs. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:950 / 960
页数:11
相关论文
共 39 条
  • [1] WHOLE-CELL ELISA FOR TYPING NEISSERIA-MENINGITIDIS WITH MONOCLONAL-ANTIBODIES
    ABDILLAHI, H
    POOLMAN, JT
    [J]. FEMS MICROBIOLOGY LETTERS, 1987, 48 (03) : 367 - 371
  • [2] *AMCRIVM, 1999, NETH REF LAB BACT ME
  • [3] EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY
    BJUNE, G
    HOIBY, EA
    GRONNESBY, JK
    ARNESEN, O
    HOLSTFREDRIKSEN, J
    HALSTENSEN, A
    HOLTEN, E
    LINDBAK, AK
    NOKLEBY, H
    ROSENQVIST, E
    SOLBERG, LK
    CLOSS, O
    ENG, J
    FROHOLM, LO
    LYSTAD, A
    BAKKETEIG, LS
    HAREIDE, B
    [J]. LANCET, 1991, 338 (8775) : 1093 - 1096
  • [4] EFFICACY, SAFETY, AND IMMUNOGENICITY OF A MENINGOCOCCAL GROUP-B (15-P1.3) OUTER-MEMBRANE PROTEIN VACCINE IN IQUIQUE, CHILE
    BOSLEGO, J
    GARCIA, J
    CRUZ, C
    ZOLLINGER, W
    BRANDT, B
    RUIZ, S
    MARTINEZ, M
    ARTHUR, J
    UNDERWOOD, P
    SILVA, W
    MORAN, E
    HANKINS, W
    GILLY, J
    MAYS, J
    [J]. VACCINE, 1995, 13 (09) : 821 - 829
  • [5] DETERMINATION OF PROTEIN SECONDARY STRUCTURE IN SOLUTION BY VACUUM ULTRAVIOLET CIRCULAR-DICHROISM
    BRAHMS, S
    BRAHMS, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1980, 138 (02) : 149 - 178
  • [6] Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
    Claassen, I
    Meylis, J
    vanderLey, P
    Peeters, C
    Brons, H
    Robert, J
    Borsboom, D
    vanderArk, A
    vanStraaten, I
    Roholl, P
    Kuipers, B
    Poolman, J
    [J]. VACCINE, 1996, 14 (10) : 1001 - 1008
  • [7] CRYSTAL-STRUCTURES EXPLAIN FUNCTIONAL-PROPERTIES OF 2 ESCHERICHIA-COLI PORINS
    COWAN, SW
    SCHIRMER, T
    RUMMEL, G
    STEIERT, M
    GHOSH, R
    PAUPTIT, RA
    JANSONIUS, JN
    ROSENBUSCH, JP
    [J]. NATURE, 1992, 358 (6389) : 727 - 733
  • [8] Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
    de Kleijn, ED
    de Groot, R
    Labadie, J
    Lafeber, AB
    van den Dobbelsteen, G
    van Alphen, L
    van Dijken, H
    Kuipers, B
    van Omme, GW
    Wala, M
    Juttmann, R
    Rümke, HC
    [J]. VACCINE, 2000, 18 (15) : 1456 - 1466
  • [9] Dellepiane N, 2000, B WORLD HEALTH ORGAN, V78, P155
  • [10] DEMORAES JC, 1992, LANCET, V340, P1074